#United States #Tempe #GammaTile #GT Medical #Mayfield Brain

GT Medical Technologies Welcomes New GammaTile® Center of Excellence Designation

GT Medical Technologies, a pioneering medical device company, proudly announces the designation of Mayfield Brain & Spine as the latest GammaTile® Center of Excellence. This recognition highlights the firm’s commitment to enhancing patient care and advancing treatments for brain tumors.

The GammaTile® program, launched to acknowledge leaders in brain tumor treatment, requires participating physicians and institutions to meet strict criteria. These include demonstrating exceptional clinical proficiency, achieving annual case minimums, and maintaining continuous education in the GammaTile procedure. This rigorous standard ensures that only top-tier facilities receive this prestigious designation, thereby benefiting patients with the most qualified care.

What is GammaTile?

GammaTile is an innovative treatment option designed specifically for patients undergoing surgical procedures for brain tumors. It integrates a delivery system that provides immediate radiation therapy right at the surgical site. This unique approach allows radiation to target remaining cancer cells effectively, reducing the chances of tumor regrowth while minimizing exposure to adjacent healthy brain tissues.

As Dr. Vincent DiNapoli, a neurosurgeon at Mayfield Brain & Spine, aptly stated, “GammaTile treatment for newly diagnosed brain tumors is a significant step forward for patients and an example of the benefits that focused neurosurgical research and clinical innovation can provide.” His remarks underline how GammaTile enhances treatment efficacy significantly compared to traditional methods, which often necessitate intervals between surgery and follow-up radiation therapy.

The medical professionals acknowledged in this milestone include a diverse group of specialists dedicated to brain cancer care:

• - Dr. Imran Chowdhury, Radiation Oncologist
• - Dr. Vincent DiNapoli, Neurosurgeon
• - Dr. David Duwel, Medical Physicist
• - Dr. Yair Gozal, Neurosurgeon
• - Dr. Courtney Hentz, Radiation Oncologist
• - Dr. Bryan Krueger, Neurosurgeon
• - Dr. Caitlin Marcum, Medical Physicist
• - Dr. Chris McPherson, Neurosurgeon
• - Dr. Marc Mosbacher, Radiation Oncologist
• - Dr. Rahul Prasad, Radiation Oncologist
• - Dr. Brock Prater, Medical Physicist
• - Dr. Michael Robinson, Neurosurgeon

The Path Forward

Since its market debut in March 2020, GammaTile has been embraced by over one hundred leading medical centers across the United States, symbolizing a rising recognition of its potential to transform brain tumor treatments. This vast adoption attests to both its clinical efficiency and acceptance within various healthcare frameworks, ranging from academic institutions to community hospitals.

GT Medical Technologies remains committed to develop humane and innovative solutions directed at enhancing the standards of brain tumor treatment. As part of this vision, the GammaTile program seeks to continuously evolve by integrating progressive methods and knowledge into brain cancer management.

The future of brain tumor treatment looks promising as innovations such as GammaTile gain traction and recognition. As this technology continues to develop, it stands to not only improve patient outcomes but also contribute to critical research in brain therapeutics.

For those interested in exploring more about the significance of GammaTile and the advancements by GT Medical Technologies, visit gammatile.com or follow them on social media platforms including Facebook, Instagram, LinkedIn, and Twitter.

Conclusion

In summary, the establishment of Mayfield Brain & Spine as a GammaTile® Center of Excellence spotlights the pivotal developments within the sphere of brain tumor treatment, reflecting how dedicated healthcare professionals strive to elevate patient care through innovative approaches. The recognition accentuates the importance of continual education and clinical excellence for pioneering groundbreaking technologies like GammaTile, fortifying the battle against brain tumors for patient longevity and quality of life.